These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4729330)

  • 21. Morphology of the intradermal phytohaemagglutinin reaction in tuberculin negative subjects.
    Plesnicar S; Ferfoglia L
    Boll Ist Sieroter Milan; 1972; 51(2):165-72. PubMed ID: 4645195
    [No Abstract]   [Full Text] [Related]  

  • 22. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 23. [Longitudinal studies on cellular immunity in patients with neoplasms].
    Spengler H; Brunner KW; de Weck A
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1167-9. PubMed ID: 5055036
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tuberculin sensitization in patients with lung cancer].
    Knoring BE; Arièl' BM
    Vopr Onkol; 1994; 40(7-12):288-93. PubMed ID: 7610622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB; Twomey PL; Trahan EE; Catalona WJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of cell-mediated effector mechanisms in lung cancer.
    Feo Figarella E; Morillo F; Blanca I; Bianco NE
    J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the surgical treatment of lung cancer].
    Leipe ER
    Vopr Onkol; 1969; 15(6):69-74. PubMed ID: 4980422
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological aspects of lung cancer].
    Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
    Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of cellular immunity in patients with malignant tumors].
    Niksic M; Balogh M; Jurin M
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(9-10):387-96. PubMed ID: 794967
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of antimitotic chemotherapy of inoperable bronchopulmonary cancer on immune processes (tuberculin allergy, immune globulins)].
    Migueres J; Jover A; Levy A
    Poumon Coeur; 1968; 24(3):351-4. PubMed ID: 4177880
    [No Abstract]   [Full Text] [Related]  

  • 32. [Attempt to include the value of life in computation of survival time in the management of the lung cancer].
    Carlens E; Dahlström G; Nöu E
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 134(3):423-6. PubMed ID: 5209392
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunologic status before and during immunotherapy (immuneprofile).
    Alth G; Denck H; Fischer M; Karrer K; Kokron O; Korizek E; Micksche M; Ogris E; Reider C; Titscher R; Wrba H
    Cancer Chemother Rep 3; 1973 Mar; 4(2):275-7. PubMed ID: 4729329
    [No Abstract]   [Full Text] [Related]  

  • 34. [Symposium on cancer and immunity. (3) Diagnostic immunological parameter in cancer patients (author's transl)].
    Yata K
    Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1495-9. PubMed ID: 744891
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunomorphology of lymph nodes and prognosis in lung cancer].
    Di Giorgio A; Sammartino P; Canavese A; Arnone P; Sibio S; Accarpio F; Al Mansour M
    Minerva Chir; 2001 Apr; 56(2):153-9. PubMed ID: 11353348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological aspects of chemotherapy for bronchial carcinomas. (author's transl)].
    Schneeweiss U
    Z Erkr Atmungsorgane; 1975 Feb; 142(2):116-26. PubMed ID: 1226877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
    Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
    Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer].
    Roviaro GC; Varoli F; Sartori F; Calabrò F; Bortolotti F; Tremolada F; Fattovich G; Cecchetto A; Paruzzolo P
    Minerva Med; 1980 Jun; 71(25):1757-67. PubMed ID: 6997779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.